Goldman Sachs Rates athenahealth (ATHN) a Neutral

Goldman Sachs transfers coverage on athenahealth (NASDAQ: ATHN) and maintains a Neutral rating and $47 price target.

Goldman has a balanced view of the stock, stating: "We may become more constructive on shares given either progress with its expensive enterprise physician group marketing efforts, or a decision to abandon the effort and deliver significant EBITDA margin expansion. We may become more negative on shares if physician adds continue to miss expectations while simultaneously increasing S&M expense margins."

For more ratings news on athenahealth click here and for the rating history of athenahealth click here.

Shares of athenahealth closed at $45.87 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
• BMO Capital Resumes Snowline Gold Corp (SGD:CN) (SNWGF) at Outperform
• Raymond James Starts SpyGlass Pharma (SGP) at Outperform